Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.

[1]  K. Caidahl,et al.  Recovery from left ventricular asynergy in ischemic cardiomyopathy following long-term beta blockade treatment. , 1994, Cardiology.

[2]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[3]  M. Lomsky,et al.  The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. , 1993, European heart journal.

[4]  D. Renlund,et al.  beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[5]  C. Pitsavos,et al.  Relation of exercise capacity in dilated cardiomyopathy to left atrial size and systolic function. , 1992, The American journal of cardiology.

[6]  A. Lahiri,et al.  Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol. , 1992, Journal of cardiovascular pharmacology.

[7]  D. Renlund,et al.  Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. , 1991, Circulation.

[8]  T. Hedner,et al.  Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. , 1991, Journal of the American College of Cardiology.

[9]  J. Corbett,et al.  Effects of bucindolol on neurohormonal activation in congestive heart failure. , 1991, The American journal of cardiology.

[10]  I. Abrass,et al.  Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy. , 1990, The American journal of cardiology.

[11]  P. Grayburn,et al.  Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. , 1990, Circulation.

[12]  D. Renlund,et al.  Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. , 1990, The American journal of medicine.

[13]  M. Packer,et al.  Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. , 1990, Circulation.

[14]  K Caidahl,et al.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. , 1989, Circulation.

[15]  T. Meinertz,et al.  Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. , 1989, Circulation.

[16]  J. Forfar,et al.  Cardiac and whole body [3H]noradrenaline kinetics in ischaemic heart disease: contrast between unstable anginal syndromes and pacing induced ischaemia. , 1989, British heart journal.

[17]  H. Valantine,et al.  Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.

[18]  J. Federman,et al.  Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. , 1984, Journal of the American College of Cardiology.

[19]  M. Schütt,et al.  Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure. , 2009, Acta medica Scandinavica. Supplementum.

[20]  J. Pontén,et al.  β‐Receptor Blockade and Spinal Anaesthesia. Withdrawal versus Continuation of Long‐term Therapy , 1982 .

[21]  S. Langlois,et al.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. , 1982, British journal of clinical pharmacology.

[22]  H. Ikram,et al.  DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHY , 1981, The Lancet.

[23]  P. Hjemdahl,et al.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.

[24]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.

[25]  V. Arkoosh,et al.  NEONATAL RESUSCITATION , 2002 .

[26]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.

[27]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.